Par Drugs and Chemicals Limited (NSE:PAR)
India · Delayed Price · Currency is INR 93.60
-0.48 (-0.51%)
May 11, 2026, 3:18 PM IST
Par Drugs and Chemicals Market Cap
Par Drugs and Chemicals has a market cap or net worth of 1.16 billion as of May 11, 2026. Its market cap has decreased by -6.10% in one year.
Market Cap
1.16B
Enterprise Value
817.83M
Revenue
1.06B
Ranking
n/a
PE Ratio
8.31
Stock Price
93.60
Market Cap Chart
Since May 16, 2019, Par Drugs and Chemicals's market cap has increased from 310.38M to 1.16B, an increase of 272.57%. That is a compound annual growth rate of 20.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.16B | -7.09% |
| Dec 31, 2025 | 1.25B | -49.09% |
| Dec 31, 2024 | 2.45B | -7.79% |
| Dec 29, 2023 | 2.65B | 42.80% |
| Dec 30, 2022 | 1.86B | -24.94% |
| Dec 31, 2021 | 2.48B | 451.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 11.98B |
| Sigachi Industries | 8.38B |
| Valiant Laboratories | 4.30B |
| Bafna Pharmaceuticals | 3.12B |
| Nectar Lifesciences | 2.79B |
| Balaxi Pharmaceuticals | 1.61B |
| Alpa Laboratories | 1.49B |
| Brooks Laboratories | 1.47B |